Cargando…
Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas
Gastric adenocarcinomas represent frequent malignant tumors in the digestive tract, with a high and constant mortality rate in last decades. The disturbance of the adhesion molecules expression, which normally is essential in maintaining epithelial homeostasis, has a critical role in the initiation...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926152/ https://www.ncbi.nlm.nih.gov/pubmed/36588491 http://dx.doi.org/10.47162/RJME.63.3.07 |
_version_ | 1784888216060428288 |
---|---|
author | Creţu, Oana Iulia Simionescu, Cristiana Eugenia Florescu, Mirela Marinela Stepan, Mioara Desdemona Sapalidis, Konstantinos Stepan, Alex Emilian |
author_facet | Creţu, Oana Iulia Simionescu, Cristiana Eugenia Florescu, Mirela Marinela Stepan, Mioara Desdemona Sapalidis, Konstantinos Stepan, Alex Emilian |
author_sort | Creţu, Oana Iulia |
collection | PubMed |
description | Gastric adenocarcinomas represent frequent malignant tumors in the digestive tract, with a high and constant mortality rate in last decades. The disturbance of the adhesion molecules expression, which normally is essential in maintaining epithelial homeostasis, has a critical role in the initiation and progression of tumors. In this study, we analyzed the immunoexpression of E-cadherin, cluster of differentiation 44 (CD44), and Claudin 7 in 58 cases of gastric adenocarcinomas, in relation to the histopathological parameters of the lesions’ aggressiveness. Increased E-cadherin immunoexpression was observed in tubular adenocarcinomas, those of low grade and in stages I–III. CD44 presented high scores in discohesive, hepatoid, tubular, and tubulopapillary adenocarcinomas, those of high grade and in advanced stages. Claudin 7 associated increased scores for tubular, tubulopapillary and micropapillary tumors, those of low grade and mainly in stage I. The markers used in the study can be useful for assessing the aggressiveness of gastric adenocarcinomas, in the context of specific adapted therapy. |
format | Online Article Text |
id | pubmed-9926152 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest |
record_format | MEDLINE/PubMed |
spelling | pubmed-99261522023-02-15 Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas Creţu, Oana Iulia Simionescu, Cristiana Eugenia Florescu, Mirela Marinela Stepan, Mioara Desdemona Sapalidis, Konstantinos Stepan, Alex Emilian Rom J Morphol Embryol Original Paper Gastric adenocarcinomas represent frequent malignant tumors in the digestive tract, with a high and constant mortality rate in last decades. The disturbance of the adhesion molecules expression, which normally is essential in maintaining epithelial homeostasis, has a critical role in the initiation and progression of tumors. In this study, we analyzed the immunoexpression of E-cadherin, cluster of differentiation 44 (CD44), and Claudin 7 in 58 cases of gastric adenocarcinomas, in relation to the histopathological parameters of the lesions’ aggressiveness. Increased E-cadherin immunoexpression was observed in tubular adenocarcinomas, those of low grade and in stages I–III. CD44 presented high scores in discohesive, hepatoid, tubular, and tubulopapillary adenocarcinomas, those of high grade and in advanced stages. Claudin 7 associated increased scores for tubular, tubulopapillary and micropapillary tumors, those of low grade and mainly in stage I. The markers used in the study can be useful for assessing the aggressiveness of gastric adenocarcinomas, in the context of specific adapted therapy. Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest 2022 2022-09-30 /pmc/articles/PMC9926152/ /pubmed/36588491 http://dx.doi.org/10.47162/RJME.63.3.07 Text en Copyright © 2022, Academy of Medical Sciences, Romanian Academy Publishing House, Bucharest https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International Public License, which permits unrestricted use, adaptation, distribution and reproduction in any medium, non-commercially, provided the new creations are licensed under identical terms as the original work and the original work is properly cited. |
spellingShingle | Original Paper Creţu, Oana Iulia Simionescu, Cristiana Eugenia Florescu, Mirela Marinela Stepan, Mioara Desdemona Sapalidis, Konstantinos Stepan, Alex Emilian Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric adenocarcinomas |
title | Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric
adenocarcinomas |
title_full | Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric
adenocarcinomas |
title_fullStr | Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric
adenocarcinomas |
title_full_unstemmed | Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric
adenocarcinomas |
title_short | Immunoexpression of E-cadherin, CD44 and Claudin 7 in gastric
adenocarcinomas |
title_sort | immunoexpression of e-cadherin, cd44 and claudin 7 in gastric
adenocarcinomas |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9926152/ https://www.ncbi.nlm.nih.gov/pubmed/36588491 http://dx.doi.org/10.47162/RJME.63.3.07 |
work_keys_str_mv | AT cretuoanaiulia immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas AT simionescucristianaeugenia immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas AT florescumirelamarinela immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas AT stepanmioaradesdemona immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas AT sapalidiskonstantinos immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas AT stepanalexemilian immunoexpressionofecadherincd44andclaudin7ingastricadenocarcinomas |